Application no. and date | 18162983.3 (espacenet) (Federated) (European Patent Register), 20140905 | Patent/reg. no. and date | DK/EP 3363790, 20200219 | Publication date | 20180822 | Priority no. and date | IN 4011CH2013, 20130906 | EP pub. no. and date |
EP 3363790 20180822 | Effective date | | Applicant/owner | Aurigene Discovery Technologies Limited, 39-40 KIADB Industrial Area Electronic City Phase-II Hosur Road
Bangalore, Karnataka 560100, IN | Applicant ref. no. | V2004-032-DK | Inventor | SASIKUMAR, Pottayil Govindan Nair, 5 Deccan Palms Ananth Nagar Phase II Electronic City Post
560100 Bangalore, IN, RAMACHANDRA, Muralidhara, V173 Adarsh Palm Retreat Outer Ring Road Bellandur Post
560103 Bangalore, IN, NAREMADDEPALLI, Seetharamaiah Setty Sudarshan, No.220, SY NO. 34/1 Ramanjini Fort House Apartment Tata Nagar, Kodigehalli
Bangalore 560092 Karnataka, IN | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/4245 (2006.01) , A61K 31/433 (2006.01) , A61P 31/04 (2006.01) , A61P 31/10 (2006.01) , A61P 31/12 (2006.01) , A61P 35/00 (2006.01) , C07D 271/06 (2006.01) , C07D 285/08 (2006.01) | Title | 1,2,4-OXADIAZOLDERIVATER SOM IMMUNMODULATORER | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|